secwatch.observer — SEC 8-K summary
======================================

Issuer:     Bone Biologics Corp (BBLG)
CIK:        0001419554
Form:       8-K
Filed at:   2024-12-13T23:59:59+00:00
Accession:  0001493152-24-050025
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Bone Biologics updates ATM offering limit to $832,009 after $846k previously sold
--------------------------------------------------------------------------------

- Filed prospectus supplement resetting ATM with H.C. Wainwright to max $832,009 in common shares.
- Previously sold approximately $846,288 under September 27, 2024 prospectus supplement.
- Shares offered under Sales Agreement dated September 27, 2024 with H.C. Wainwright & Co.
- Legal opinion from Harter Secrest & Emery LLP on share legality filed as Exhibit 5.1.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1419554/000149315224050025/0001493152-24-050025-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1419554/000149315224050025/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-24-050025

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer